Results for the Fourth Quarter and Full Year 2025

Posted on
February 27, 2026
by Medistim

Record Sales and Strong Profit Growth in Q4 and Full Year

‍

The company delivered record sales in both the fourth quarter and full year, with revenue increasing 20.6% in Q4 to MNOK 182.3 and 24.4% for the year to MNOK 699.8.

‍

Currency-neutral sales of own products grew 25.0% in the quarter and 28.3% for the full year, demonstrating continued strong underlying demand.

‍

Regional performance in Q4 was led by AMERICAS (+44.3%) and EMEA (+24.4%) while APAC declined 24.2% in the quarter but remains up 40.0 % year to date. Scandinavia distributor sales increased 2.2% in the quarter.

‍

Profitability improved significantly, with EBIT growing 64%in Q4 to MNOK 42.3 (23.2% EBITmargin).

‍

For the full year, AMERICAS grew 36 %, APAC region at 40 %, EMEA at 8 % while the 3rd party sale grew 12.7 %. EBIT increased 50% to MNOK 196.2, resulting in a strong 28.3% margin.

‍

Read the full result and presentation here: Q4-2025 Results